22+ hour, 4+ min ago  (208+ words) Shares in Roche dipped in Zurich on Monday after the company's breast-cancer treatment, Giredestrant, failed to meet its primary objective in a late-stage clinical trial. The Swiss pharma giant, which had predicted that annual sales of Giredestrant would peak at…...